LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 302

Search options

  1. Article ; Online: Lessons from STIMULI: who benefits from consolidation nivolumab and ipilimumab in limited-disease small-cell lung cancer after chemo-radiotherapy?

    Reinmuth, Niels

    Annals of palliative medicine

    2022  Volume 11, Issue 9, Page(s) 3028–3031

    MeSH term(s) Chemoradiotherapy ; Humans ; Ipilimumab/therapeutic use ; Lung Neoplasms/drug therapy ; Nivolumab/therapeutic use ; Small Cell Lung Carcinoma/drug therapy ; Small Cell Lung Carcinoma/radiotherapy
    Chemical Substances Ipilimumab ; Nivolumab (31YO63LBSN)
    Language English
    Publishing date 2022-08-11
    Publishing country China
    Document type Journal Article
    ZDB-ID 2828544-X
    ISSN 2224-5839 ; 2224-5839
    ISSN (online) 2224-5839
    ISSN 2224-5839
    DOI 10.21037/apm-22-857
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Tumoren der Lunge. Weiterer ECFR-Antikörper in der Erstlinientherapie des NSCLC getestet. Thatcher N et al. Lancet Oncol. 2015;16(7):763-74. kommentiert von Niels Reinmuth, Großhansdorf

    Reinmuth, Niels

    Im Focus Onkologie

    2015  Volume 18, Issue 12, Page(s) 24

    Language German
    Document type Article
    ZDB-ID 2044841-7
    ISSN 1435-7402
    Database Current Contents Medicine

    More links

    Kategorien

  3. Article: Reexposition mit Checkpoint-Inhibitoren (Recheck). Eine randomisierte Phase-II-Studie zur Sicherheit und Effizienz von Durvaiumab plusTremelimumab versus fortgesetzte Chemotherapie nach 2 Zyklen platinbasierter Chemotherapie bei Patienten mit progredientem NSCLC und Erstlinien-Checkpoint-Inhibitor-Monotherapie

    Reinmuth, N.

    Forum / Deutsche Krebsgesellschaft

    2022  Volume 37, Issue 3, Page(s) 237

    Language German
    Document type Article
    ZDB-ID 1218650-8
    ISSN 0947-0255
    Database Current Contents Medicine

    More links

    Kategorien

  4. Article: Molekular basierte Behandlungsstrategien beim NSCLC mit Treiberalterationen

    Reinmuth, Niels

    Trillium-Krebsmedizin

    2022  Volume 31, Issue 3, Schwerpunkt Lungentumoren, Page(s) 163

    Language German
    Document type Article
    ZDB-ID 2768536-6
    ISSN 2198-9818
    Database Current Contents Medicine

    More links

    Kategorien

  5. Article: State of the Art - zielgerichtete Therapie. State of the art - targeted therapy

    Reinmuth, N.

    Atemwegs- und Lungenkrankheiten

    2021  Volume 47, Issue 3, Page(s) 113

    Language German
    Document type Article
    ZDB-ID 534006-8
    ISSN 0341-3055
    Database Current Contents Medicine

    More links

    Kategorien

  6. Article ; Online: Lungenkrebsscreening – wer, wo und wie?

    Reinmuth, Niels

    Deutsche medizinische Wochenschrift (1946)

    2019  Volume 144, Issue 24, Page(s) 1721–1725

    Abstract: In large clinical studies, lung cancer screening has been demonstrated to be effective in reducing lung cancer mortality in defined high risk populations using low-dose CT techniques. However, in different studies, results and definitions of persons of ... ...

    Title translation Lung Cancer screening? Who should get it and how it should be done.
    Abstract In large clinical studies, lung cancer screening has been demonstrated to be effective in reducing lung cancer mortality in defined high risk populations using low-dose CT techniques. However, in different studies, results and definitions of persons of high risk have varied which needs to be taken into account when screening programmes should be implemented in clinical routine. In order those programmes to be as effective as possible, the careful definition of a risk population is crucial as much as the careful use of radiant exposure. Ideally, the number of false positive findings should be as low as possible with the best reduction in lung cancer mortality and limited financial burden.
    MeSH term(s) Cost-Benefit Analysis ; Early Detection of Cancer ; Humans ; Lung/diagnostic imaging ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/mortality ; Radiation Exposure ; Risk Factors ; Tomography, X-Ray Computed
    Language German
    Publishing date 2019-12-02
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 200446-x
    ISSN 1439-4413 ; 0012-0472
    ISSN (online) 1439-4413
    ISSN 0012-0472
    DOI 10.1055/a-0965-9413
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Nichtkleinzelliges Lungenkarzinom. PD Dr. med. Niels Reinmuth. Bei der ASCO-Jahrestagung wurde die Entwicklung zur Therapie früher Stadien besonders diskutiert

    Reinmuth, Niels

    TZM-News

    2021  Volume 23, Issue 3, Page(s) 20214

    Language German
    Document type Article
    ZDB-ID 1497189-6
    ISSN 1437-8019
    Database Current Contents Medicine

    More links

    Kategorien

  8. Article: New data: new options for front-line therapy in NSCLC?

    Reinmuth, Niels

    ESMO open

    2018  Volume 3, Issue 3, Page(s) e000369

    Language English
    Publishing date 2018-04-23
    Publishing country England
    Document type Editorial
    ISSN 2059-7029
    ISSN 2059-7029
    DOI 10.1136/esmoopen-2018-000369
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Kleinzelliges Lungenkarzinom.

    Reinmuth, N / Hoffmann, H

    Pneumologie (Stuttgart, Germany)

    2021  Volume 75, Issue 4, Page(s) e1

    Title translation Small Cell Lung Cancer.
    Language German
    Publishing date 2021-09-22
    Publishing country Germany
    Document type Journal Article ; Published Erratum
    ZDB-ID 607630-0
    ISSN 1438-8790 ; 0934-8387
    ISSN (online) 1438-8790
    ISSN 0934-8387
    DOI 10.1055/a-1643-8827
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Kleinzelliges Lungenkarzinom.

    Reinmuth, N / Hoffmann, H

    Pneumologie (Stuttgart, Germany)

    2021  Volume 75, Issue 4, Page(s) 304–318

    Abstract: Small cell lung cancer is an aggressive cancer entity and characterized by rapid progression, early distant metastasis and poor prognosis. Only the minority of patients presents with a non-metastatic stage disease where chemo-radiotherapy or - in very ... ...

    Title translation Small Cell Lung Cancer.
    Abstract Small cell lung cancer is an aggressive cancer entity and characterized by rapid progression, early distant metastasis and poor prognosis. Only the minority of patients presents with a non-metastatic stage disease where chemo-radiotherapy or - in very selected cases - even surgical resection may be discussed. For most patients, the efficacy of systemic therapy is crucial. However, although most patients respond to platinum doublet chemotherapy, virtually all patients with metastatic disease eventually develop tumor progression for which there are limited treatment options. Recently and for the first time since decades, the systemic approaches have been enriched by the implementation of immunotherapy. Moreover, novel therapeutic approaches such as new cytotoxic agents or further immune modulatory strategies are being tested in clinical studies that might broaden our treatment options in the future even further.
    MeSH term(s) Antineoplastic Agents/therapeutic use ; Humans ; Immunotherapy ; Lung Neoplasms/drug therapy ; Small Cell Lung Carcinoma/drug therapy
    Chemical Substances Antineoplastic Agents
    Language German
    Publishing date 2021-04-19
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 607630-0
    ISSN 1438-8790 ; 0934-8387
    ISSN (online) 1438-8790
    ISSN 0934-8387
    DOI 10.1055/a-0982-0375
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top